Table 3 Ovarian cancer patient survival: 5-year survival for hCG positive and negative tumors with regard to LH receptor (LH-R) and FSH receptor (FSH-R) expression
From: Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer
Ovarian cancer patient 5-year survival (%) | LH-R positive and FSH-R negative | FSR-R and LH-R positive/FSH-R and LH-R negative | FSH-R positive and LH-R negative |
|---|---|---|---|
hCG negative | 50.5 | 44.9 | 30.0 |
hCG positive | 75.0 | 39.8 | 25.0 |